Cytokinetics | CYTK - Assets



Cytokinetics reported $1.23B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Acadia Pharmaceuticals USD 1.23B 93.19M Jun/2025
Amgen USD 87.9B 1.47B Jun/2025
Bayer EUR 105.24B 3.95B Jun/2025
Biogen USD 28.33B 297.1M Jun/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
Cytokinetics USD 1.23B 38.42M Jun/2025
Eisai JPY 1.41T 23.07B Jun/2025
Eli Lilly USD 100.92B 11.53B Jun/2025
Exelixis USD 2.68B 159.17M Jul/2025
Geron USD 555.2M 7.25M Jun/2025
Halozyme Therapeutics USD 2.05B 142.63M Jun/2025
Ionis Pharmaceuticals USD 2.99B 172.18M Jun/2025
Ligand Pharmaceuticals USD 948.6M 43.17M Jun/2025
Merck USD 117.52B 2.4B Jun/2025
Novartis USD 104.4B 4.45B Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
Regeneron Pharmaceuticals USD 38.22B 674M Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
Sanofi 124.96B 6.93B Jun/2025